adplus-dvertising
Close Menu
Breaking News:
Subscribe
Business News Harry MillerBy

Gilead says additional data on remdesivir shows improved clinical recovery – Yahoo Canada Finance


July 10 (Reuters) – Gilead Sciences Inc said on Friday additional data from a late-stage study showed its antiviral remdesivir significantly improved clinical recovery in severely ill COVID-19 patients.

Findings from an analysis of its late-stage study showed that 74.4% of remdesivir-treated patients recovered by Day 14 versus 59.0% of patients receiving standard of care, the company said.

Gilead shares were up nearly 2% at $76.14 before the bell. (Reporting by Ankur Banerjee in Bengaluru; editing by Uttaresh.V)

Let’s block ads! (Why?)

728x90x4

Source link

Share.

Harry Miller is a writer and editor based in Toronto with 14 years of experience in the journalism industry. Before joining Canada News Media as a National Online Journalist, Miller worked as a senior writer and a reporter-editor with the Canadian Press and as a breaking news reporter with the Toronto Star. At Canada News Media he covers national news and the trending stories Canadians are searching for. Miller holds two bachelor's degrees, one in journalism from Ryerson University and another in communications and film studies from Carleton University.

Related Posts